Dr. Eric Denkers awarded R21
-News-
Posted: Apr 29, 2016 - 01:31pm
CETI Investigator Dr. Eric Denkers has been awarded NIH R21 funds for his project, "Basis of MyD88-independent Th1 immunity during Toxoplasma infection". Dr. Denkers recently joined the CETI program as director of the Cell Biology Core.